Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

1 envelope glycoprotein. In GeoVax's second generation vaccine, the DNA prime co-expresses GM-CSF with the virus-like particles, delivering a normal human protein that stimulates immune responses to the site of vaccination. All preventative Phase 1 human clinical trials conducted to date tested various combinations and doses of our DNA and MVA vaccines, their ability to raise anti-HIV humoral (antibody) and cellular (cytotoxic T cell) immune responses, as well as the vaccines' safety.

About HIV/AIDSAIDS is an epidemic that can affect anyone, regardless of race, gender, age or sexual orientation. 33 million people are currently infected globally and it is estimated that there will be 2.5 million new infections this year. Since the beginning of the epidemic, over a million people in the U.S. have contracted the virus. Every 9-1/2 minutes, someone in the U.S. is infected with AIDS. Globally, HIV is the top killer among women of reproductive age. HIV is a worldwide disease with different subtypes (or clades) of the virus predominating in different regions of the world. Clade B is the predominant subtype in North America. Globally, most infections involve subtypes AG, B, and C. GeoVax vaccines are currently designed to function against clade B.

For more information, please visit www.geovax.com.

Forward-Looking StatementsCertain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: HVTN will commence, complete enrollment, and generate data regarding GeoVax vaccine clinical trials as and when expected, GeoVax can develop and manufacture its vaccines with the desired characteristics
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 UBM Medica US ... a new online community and information resource for neurologists ... and treat their patients with neurological disorders . ... an aging population, necessitates greater access to dedicated information ... statistics on neurological conditions include: , 1 ...
(Date:7/23/2014)... July 23, 2014 Research and Markets ... (ECG) Market by Product, End-user & by Lead Type ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... into three major segments, namely, holter monitor, resting, and ... valued at $3,683 million in 2013 and is poised ...
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
... June 29 Max Neeman International, India ,s ... extended the platform to provide expert CDISC (Clinical Data Interchange Standards ... data conversion, implementation of CDISC standards and CDISC compliance checks. , ... CDISC SDTM (Standard ...
... IRVINE, Calif. , June 29 Avrio Biopharmaceuticals, ... of David A. Gelber as the Director of Manufacturing. ... production systems and ensuring clients receive high quality service in a ... , ...
Cached Medicine Technology:Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model 2Avrio Appoints David L. Gelber to Director of Manufacturing 2Avrio Appoints David L. Gelber to Director of Manufacturing 3
(Date:7/23/2014)... (PRWEB) July 23, 2014 Inventor and ... From football games to the gas pump – sharing ... on Wednesday, July 30 at Noon. , With 24 ... has more patents than anyone in the General Assembly ... superimposed yellow line yard marker as seen on television, ...
(Date:7/23/2014)... (HealthDay News) -- Regularly checking the pulse of a ... "Screening pulse is the method of choice for ... who have never had a stroke. Our study shows ... way to identify people who might need more thorough ... Dr. Bernd Kallmunzer, of Erlangen University in Germany. ...
(Date:7/23/2014)... Officials from China,s Northwest Agricultural and Forestry University in ... signed a memorandum of agreement that lays the groundwork ... Safety in China. , The signing ceremony was held ... between high-level officials of the U.S. Department of Agriculture ... agreement is a landmark event for UC Davis and ...
(Date:7/23/2014)... Rich Dad® Education, a leader in financial education, is ... to support Habit for Humanity of Lee and Hendry Counties. ... be donated to Habitat for Humanity. Additionally, all the items ... Habitat for Humanity ReStore thrift store located at 31 Willis ... the highlights of the yard sale was a visit from ...
(Date:7/23/2014)... Los Angeles, CA (PRWEB) July 23, 2014 ... physician practices delivering Enhanced External Counterpulsation (EECP), ... patient who receives EECP therapy at the health center. ... and ischemic heart disease. Since receiving ongoing EECP therapy ... , When Sara Soulati, CEO of Global Cardio ...
Breaking Medicine News(10 mins):Health News:Celebrating Innovation and Invention 2Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2
... , , MOUNTAIN VIEW, Calif., Aug. 3 ... results for the second quarter ended June 30, 2009. , , ... was $5.0 million, compared to $16.5 million during the same period in ... $14.9 million, compared to $30.8 million for the first six months of ...
... , , SAN DIEGO, Aug. 3 ... Chairman of the Department of Genetics at The Scripps Research Institute ... both the National Academy of Sciences and the Institute of Medicine, ... of the largest and most prestigious awards for medicine in the ...
... , , , ... Communications Inc. , an independent, full-service, high-tech public relations ... to its client portfolio of industry-leading technology companies. A ... turned to Sterling to create a communications strategy that will ...
... BOCA RATON, Fla., Aug. 3 MadZone Marketing LLC, ... firm, TransMedia Group, to publicize its wackiest of all offerings, the ... ( www.knifeandforklift.com ). , ... and Forklift sets are a sleek combo of utensils and dumbbells ...
... DETROIT, Aug. 3 Caraco Pharmaceutical Laboratories, Ltd. ... has executed a settlement agreement with MedImmune, stipulating the dismissal ... for the District of Maryland regarding the submission of an ... Ethyol(R). , , Under the settlement agreement, ...
... drugs is safe and effective for patients beginning treatment against ... phase III clinical trial comparing it with standard antiretroviral drugs. ... an upcoming issue of the Lancet . Lead ... of medicine (infectious diseases) at Emory University School of Medicine. ...
Cached Medicine News:Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 3Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 4Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 5Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 6Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 7Health News:Professor Bruce Beutler Joins aTyr Pharma's Scientific Advisory Board 2Health News:Knome Selects Sterling Communications as Agency of Record 2Health News:Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift(TM) 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation 2Health News:HIV integrase inhibitor effective for patients beginning antiretroviral treatment 2
... low-price PC-based, 2-8-channel system for measuring ... retina and the optic nerve. The ... monitor, printer, keyboard, mouse, bioelectrical amplifier, ... connections are easily to install. The ...
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
The only air-based esthesiometer with a database of normal sensation on the cornea. May have application to the measurement of normal-tension glaucoma....
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
Medicine Products: